Saturday 17 October 2026 Export COO’s income statement to Excel — free account

The Cooper Companies, Inc.

COO Healthcare Medical Instruments & Supplies

The Cooper Companies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $4.1 billion, up 5.06% from fiscal 2024. In the quarter to July 2026, revenue was flat, EPS grew 357.1%, free cash flow grew 66.0% and total debt rose 2.66%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five; insiders bought in the last twelve months.

57.94 0.54 +0.94%

Follow COO

Alert me

Market cap: $10.9B
P/E: 19.8×
Fwd P/E: 28.7×
Dividend yield: —
F-score: 5/9
Altman Z: 3.48
Beneish M: −2.50
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Insider Decisions trades per month

Total buys 3.18

Totals in millions of $.

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	5	—	—	—	—	—	—	—	—	4	—
Sell	—	—	—	—	—	—	—	—	—	—	—	—

Insider Ownership 2.10%

Capital & Financial Ratios $m

Market Cap 10,910.00

Revenue 4,236.90

Net Income 570.30

Free Cash Flow 678.00

Net Debt 2,389.50

Current Ratio 1.22

Debt/Equity 0.31

P/E ratio 19.77

Fwd P/E 28.70

P/S ratio 2.64

P/B ratio 1.34

Past 5Y EPS Growth 9.23%

This Y EPS Growth 10.25%

Next Y EPS Growth 3.55%

Next Y revenue growth 3.58%

Next 5Y EPS Growth 7.42%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/E against its own 10 years 12.61%

10-year low 10-year high

P/S against its own 10 years 1.00%

10-year low 10-year high

P/B against its own 10 years 1.00%

10-year low 10-year high

EV/Sales against its own 10 years 1.00%

10-year low 10-year high

EV/FCF against its own 10 years 1.00%

10-year low 10-year high

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

	total	individual payouts
2028	Powerpack
2027	Powerpack
2026	Powerpack
2025	Powerpack
2024	Powerpack
2023	0.02	0.01 0.01
2022	0.02	0.01 0.01
2021	0.02	0.01 0.01
2020	0.02	0.01 0.01
2019	0.02	0.01 0.01
2018	0.02	0.01 0.01
2017	0.02	0.01 0.01
2016	0.02	0.01 0.01

predictions special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	121	108	111	155
Receivables	610	717	829	789
Inventory	736	803	846	912
Other	—	—	—	—
	1,705	1,952	2,106	2,282

	2023	2024	2025	Q'26
Payables	262	261	300	251
ST’ Debt	45	33	48	628
Other	363	424	426	367
	969	1,023	1,113	1,867

Compound Annual Growth %

	10y	5y	3y
Sales	8.58%	10.98%	7.35%
Cash Flow	7.37%	10.35%	4.76%
Earnings	6.30%	9.48%	(0.95%)
Book Value	11.91%	16.59%	4.72%

Revenue $m

	Jan	Apr	Jul	Oct	Year
’26	1,024	1,082	1,066	—	—
’25	965	1,002	1,060	1,065	4,092
’24	932	943	1,003	1,018	3,895
’23	859	877	930	927	3,593
’22	787	830	843	848	3,308
’21	681	720	763	759	2,923
’20	646	525	578	682	2,431

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Jan	Apr	Jul	Oct	Year
’26	261	183	342	—	—
’25	191	96	261	248	796
’24	123	111	208	268	709
’23	167	124	143	174	608
’22	166	132	264	131	692
’21	148	193	224	175	739
’20	130	26	113	218	487

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Jan	Apr	Jul	Oct	Year
’26	159	96	273	—	—
’25	101	18	165	150	434
’24	5	37	119	128	288
’23	84	51	52	29	215
’22	109	88	217	36	450
’21	92	143	180	110	524
’20	61	(63)	68	111	176

Fiscal quarters ending in the months shown.

EPS $

	Jan	Apr	Jul	Oct	Year
’26	0.66	(0.40)	2.24	—	—
’25	0.52	0.44	0.49	0.43	1.87
’24	0.41	0.44	0.52	0.58	1.96
’23	0.43	0.20	0.43	0.43	1.48
’22	0.48	0.64	0.50	0.33	1.94
’21	10.58	0.59	3.09	0.55	14.79
’20	0.46	0.06	0.28	0.41	1.20

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	29.82	43.51	54.12	60.43	59.17	88.26	61.06	75.94	84.76	61.78	Analyst estimates 2026–2028 Powerpack
	High	47.75	64.10	70.80	86.08	92.90	115.90	107.67	99.91	112.38	100.24
People
People	Employees	10,600	11,800	12,000	12,000	12,000	12,000	14,000	15,000	16,000	15,000
	Revenue/emp, $m	0.19	0.18	0.21	0.22	0.20	0.24	0.24	0.24	0.24	0.27
Income, $m
Income, $m	Revenue	1,967	2,139	2,533	2,653	2,431	2,923	3,308	3,593	3,895	4,092
	Gross margin, %	59.65	63.85	64.45	66.21	63.14	66.92	64.67	65.62	66.64	65.54
	EBT	296	394	332	477	267	492	475	413	582	567
	EBT margin, %	15.03	18.42	13.10	17.99	10.96	16.82	14.37	11.49	14.95	13.84
	Net income	275	373	140	467	238	2,945	386	294	392	375
	Depreciation	198	188	275	281	287	309	346	368	375	377
Per share, $
Per share, $	Revenue	10.14	10.94	12.90	13.43	12.38	14.85	16.76	18.16	19.58	20.55
	Earnings	1.40	1.88	0.70	2.33	1.20	14.79	1.94	1.48	1.96	1.87
	Cash flow	2.63	3.03	3.41	3.61	2.48	3.75	3.51	3.07	3.57	4.00
	Capex	(0.79)	(0.65)	(0.99)	(1.48)	(1.58)	(1.09)	(1.23)	(1.98)	(2.12)	(1.82)
	Free cash flow	1.84	2.38	2.42	2.13	0.90	2.66	2.28	1.09	1.45	2.18
	Book value	13.90	16.24	16.84	18.36	19.47	35.27	36.35	38.16	40.64	41.38
	Shares, m	194	196	196	198	196	197	197	198	199	199
Valuation, ×
Valuation, ×	P/E	31.49	31.95	92.92	31.16	66.64	7.12	35.23	52.75	53.68	37.19
	P/S	4.34	5.49	5.01	5.42	6.47	7.10	4.08	4.29	5.35	3.40
	P/B	3.17	3.70	3.83	3.96	4.11	2.99	1.88	2.04	2.58	1.69
	EV/Sales	4.97	6.00	5.78	6.07	7.16	7.58	4.87	4.97	5.98	3.99
	EV/FCF	27.37	27.52	30.78	38.26	98.84	42.25	35.78	83.13	80.86	37.62
Cash, $m
Cash, $m	Operating cash flow	510	594	669	713	487	739	692	608	709	796
	Capex	(153)	(127)	(194)	(292)	(310)	(214)	(242)	(392)	(421)	(362)
	Free cash flow	357	466	475	421	176	524	450	215	288	434
Balance, $m
Balance, $m	Working capital	394	557	554	53	270	733	253	736	929	994
	Total debt	1,334	1,173	2,023	1,826	1,793	1,481	2,763	2,569	2,584	2,505
	Net debt	1,233	1,084	1,945	1,737	1,677	1,385	2,625	2,448	2,476	2,395
	Shareholders’ equity	2,696	3,176	3,308	3,629	3,825	6,942	7,175	7,551	8,084	8,239
Returns, %
Returns, %	ROA	6.13	7.99	2.55	7.54	3.66	36.03	3.66	2.54	3.27	3.03
	ROIC	5.16	6.30	4.80	6.37	3.54	3.80	3.24	3.33	4.18	4.01
	ROE	10.20	12.70	4.32	13.46	6.40	54.70	5.47	4.00	5.02	4.59

Negative figures in brackets.

All 10 years →

Fiscal years to Oct 2025 · latest quarter Jul 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
SOLV Solventum Corporation	$15.0B	10.4×	39.0×	+2.22% (above 0%: growing)	+1.92% (above 0%: growing)	+144.07% (above 0%: growing)	58.22%	8.19%	Compare
BAX Baxter International Inc.	$13.3B	— (loss-making)	44.7×	+5.34% (above 0%: growing)	+33.33% (above 0%: growing)	+119.48% (above 0%: growing)	34.86%	7.33%	Compare
RGEN Repligen Corporation	$11.7B	234×	112×	+11.93% (above 0%: growing)	−65.38% (below 0%: shrinking)	+27.10% (above 0%: growing)	53.91%	6.85%	Compare
COO The Cooper Companies, Inc.	$10.9B	19.8×	28.7×	+0.56% (above 0%: growing)	+357.14% (above 0%: growing)	+65.96% (above 0%: growing)	66.77%	20.82%
AVTR Avantor, Inc.	$10.9B	— (loss-making)	25.5×	+0.53% (above 0%: growing)	−33.33% (below 0%: shrinking)	+12.66% (above 0%: growing)	31.73%	7.20%	Compare
ALGN Align Technology, Inc.	$10.6B	25.6×	20.7×	+4.32% (above 0%: growing)	−12.21% (below 0%: shrinking)	+85.77% (above 0%: growing)	71.71%	14.58%	Compare
ATR AptarGroup, Inc.	$7.9B	22.2×	21.0×	+6.26% (above 0%: growing)	−18.34% (below 0%: shrinking)	−23.07% (below 0%: shrinking)	35.61%	12.34%	Compare
BLCO Bausch + Lomb Corporation	$6.0B	— (loss-making)	— (loss-making)	+9.08% (above 0%: growing)	n/m	+251.85% (above 0%: growing)	62.20%	5.95%	Compare
TFX Teleflex Incorporated	$5.4B	— (loss-making)	45.3×	+28.88% (above 0%: growing)	−17.33% (below 0%: shrinking)	+220.14% (above 0%: growing)	58.16%	12.77%	Compare
Median of peers	$10.7B	23.9×	39.0×	+5.80%	−17.33%	+102.63%	56.04%	7.76%

All 55 Medical Instruments & Supplies stocks →

The Cooper Companies, Inc. (COO) key facts

Concern: Net income was $374.9 million, or $1.87 per share (basic), a net margin of 9.16%.
Strength: The Cooper Companies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $4.1 billion, up 5.06% from fiscal 2024.
The Cooper Companies, Inc. (COO) is a Medical Instruments & Supplies company in the Healthcare sector, listed on Nasdaq.
As of October 16, 2026, COO traded at $57.94, a market capitalization of $10.9 billion.
At that price the stock trades at 19.8× trailing-twelve-month earnings and 2.6× sales; its P/E is higher than 13% of its own readings over the past ten years.
Return on equity was 4.59% and debt-to-equity 0.31.
Its Piotroski F-score is 5 out of 9 and its Altman Z-score is 3.48 (safe zone) for fiscal 2025.